Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Philippe Chaignon"'
Publikováno v:
Molecules, Vol 27, Iss 3, p 708 (2022)
The non-mevalonate or also called MEP pathway is an essential route for the biosynthesis of isoprenoid precursors in most bacteria and in microorganisms belonging to the Apicomplexa phylum, such as the parasite responsible for malaria. The absence of
Externí odkaz:
https://doaj.org/article/ea55bfc9c843423b839ed35c89525269
Autor:
Jean-Luc Ferrer, Philippe Chaignon, Alain Wagner, Franck Borel, Zoljargal Baatarkhuu, Myriam Seemann
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports
Scientific Reports, 2018, 8 (1), pp.17892. ⟨10.1038/s41598-018-35586-y⟩
Scientific Reports, Nature Publishing Group, 2018, 8 (1), pp.17892. ⟨10.1038/s41598-018-35586-y⟩
Scientific Reports
Scientific Reports, 2018, 8 (1), pp.17892. ⟨10.1038/s41598-018-35586-y⟩
Scientific Reports, Nature Publishing Group, 2018, 8 (1), pp.17892. ⟨10.1038/s41598-018-35586-y⟩
As multidrug resistant pathogenic microorganisms are a serious health menace, it is crucial to continuously develop novel medicines in order to overcome the emerging resistance. The methylerythritol phosphate pathway (MEP) is an ideal target for anti
Autor:
Annegret Reinhard, C. Dale Poulter, Hans-Christian Wille, Myriam Seemann, Juliusz A. Wolny, Isabelle Faus, Volker Schünemann, S. Rackwitz, Kai Schlage, Philippe Chaignon, Aleksandr I. Chumakov, Sergiy Krasutsky
Publikováno v:
Angewandte Chemie. 127:12771-12775
Das Protein LytB/ISPH katalysiert den letzten Schritt des Methylerythritolphosphat(MEP)-Wegs, der zur Terpenoidbiosynthese in vielen pathogenen Bakterien dient. Deswegen gilt der MEP-Weg als Angriffspunkt fur neue potentielle Antibiotika, da er essen
Autor:
Isabelle Faus, Juliusz A. Wolny, S. Rackwitz, Kai Schlage, Hans-Christian Wille, Sergiy Krasutsky, C. Dale Poulter, Aleksandr I. Chumakov, Annegret Reinhard, Volker Schünemann, Philippe Chaignon, Myriam Seemann
Publikováno v:
Angewandte Chemie International Edition. 54:12584-12587
The LytB/IspH protein catalyzes the last step of the methylerythritol phosphate (MEP) pathway which is used for the biosynthesis of essential terpenoids in most pathogenic bacteria. Therefore, the MEP pathway is a target for the development of new an
Autor:
Myriam Seemann, Sergiy Krasutsky, Philippe Chaignon, C. Dale Poulter, Michel Rohmer, Karnjapan Janthawornpong
Publikováno v:
Journal of the American Chemical Society. 135:1816-1822
The MEP pathway, which is absent in animals but present in most pathogenic bacteria, in the parasite responsible for malaria and in plant plastids, is a target for the development of antimicrobial drugs. IspH, an oxygen-sensitive [4Fe–4S] enzyme, c
Autor:
Jamal Ouazzani, Philippe Chaignon, Gilles Truan, Philippe Meyer, Sylvie Cortial, Solange Moréra, Stéphane Aymerich, Virginie Gueguen-Chaignon, Bogdan I. Iorga
Publikováno v:
FEBS Letters
FEBS Letters, Wiley, 2010, 584 (18), pp.3916-22. ⟨10.1016/j.febslet.2010.08.019⟩
FEBS Letters, Wiley, 2010, 584 (18), pp.3916-22. ⟨10.1016/j.febslet.2010.08.019⟩
NfrA1 nitroreductase from the Gram-positive bacterium Bacillus subtilis is a member of the NAD(P)H/FMN oxidoreductase family. Here, we investigated the reactivity, the structure and kinetics of NfrA1, which could provide insight into the unclear biol
Autor:
Grigorij Kogan, Ali Chokr, Philippe Chaignon, Saïd Jabbouri, Irina Sadovskaya, Evgeny Vinogradov
Publikováno v:
FEMS Immunology & Medical Microbiology. 47:75-82
The capacity of coagulase-negative staphylococci to colonize implanted medical devices is generally attributed to their ability to produce biofilms. Biofilm of the model strain of Staphylococcus epidermidis RP62A was shown to contain two carbohydrate
Publikováno v:
FEMS Microbiology Letters. 255:11-16
Staphylococcus aureus and coagulase-negative staphylococci, primarily Staphylococcus epidermidis, are recognized as a major cause of nosocomial infections associated with the use of implanted medical devices. The capacity of S. epidermidis to form bi
Publikováno v:
Journal of Molecular Catalysis B: Enzymatic
Journal of Molecular Catalysis B: Enzymatic, Elsevier, 2012, 76, pp.761-768. ⟨10.1016/j.molcatb.2011.11.014⟩
Journal of Molecular Catalysis B: Enzymatic, Elsevier, 2012, 76, pp.761-768. ⟨10.1016/j.molcatb.2011.11.014⟩
Nfr-A1, a Bacillus subtilis nitroreductase, catalyzes the nitroreduction of a large panel of aromatic and heterocyclic nitro compounds, except those belonging to nitrouracil class of molecules. Besides nitroreduction, Nfr-A1 exhibits a strong NADH ox
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::864eb142468a98960d96461852fa6107
https://hal.archives-ouvertes.fr/hal-00690886
https://hal.archives-ouvertes.fr/hal-00690886
Autor:
A.P. Ventura, Philippe Lopes, Frédéric Halgand, Sylvie Cortial, Philippe Chaignon, Olivier Laprévote, Jamal Ouazzani
Publikováno v:
Enzyme and Microbial Technology
Enzyme and Microbial Technology, Elsevier, 2006, 39(7), pp.1499-1506. ⟨10.1016/j.enzmictec.2006.04.023⟩
Enzyme and Microbial Technology, Elsevier, 2006, 39(7), pp.1499-1506. ⟨10.1016/j.enzmictec.2006.04.023⟩
We have investigated a specific enzymatic biosensor for detecting target pollutant 3,5-dinitro-trifluoromethylbenzene (3,5-DNBTF). The predicted enzyme is a nitroreductase that catalyzes the total nitroreduction of 3,5-DNBTF to its corresponding diam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::030040131857d17ebef752e2932b6233
https://hal.archives-ouvertes.fr/hal-00114082
https://hal.archives-ouvertes.fr/hal-00114082